Patents by Inventor Steven Wayne Riesinger

Steven Wayne Riesinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
    Patent number: 11701366
    Abstract: Provided are methods of treating a cerebral cavernous malformation (CCM) and methods of treating cerebral aneurysm in a mammal with certain rho kinase inhibitors.
    Type: Grant
    Filed: December 7, 2020
    Date of Patent: July 18, 2023
    Assignee: BioAxone BioSciences, Inc.
    Inventors: Kenneth M. Rosen, Steven Wayne Riesinger, Lisa McKerracher, Lisa Bond Moritz
  • TREATMENT OF CEREBRAL CAVERNOUS MALFORMATIONS AND CEREBRAL ANEURYSMS WITH RHO KINASE INHIBITORS
    Publication number: 20210290635
    Abstract: Provided are methods of treating a cerebral cavernous malformation (CCM) and methods of treating cerebral aneurysm in a mammal with certain rho kinase inhibitors.
    Type: Application
    Filed: December 7, 2020
    Publication date: September 23, 2021
    Inventors: Kenneth M. ROSEN, Steven Wayne RIESINGER, Lisa MCKERRACHER, Lisa BOND MORITZ
  • Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
    Patent number: 10857157
    Abstract: Provided are methods of treating a cerebral cavernous malformation (CCM) and methods of treating cerebral aneurysm in a mammal with certain rho kinase inhibitors.
    Type: Grant
    Filed: December 10, 2018
    Date of Patent: December 8, 2020
    Assignee: BioAxone BioSciences, Inc.
    Inventors: Kenneth M. Rosen, Steven Wayne Riesinger, Lisa McKerracher, Lisa Bond Moritz
  • TREATMENT OF CEREBRAL CAVERNOUS MALFORMATIONS AND CEREBRAL ANEURYSMS WITH RHO KINASE INHIBITORS
    Publication number: 20190298733
    Abstract: Provided are methods of treating a cerebral cavernous malformation (CCM) and methods of treating cerebral aneurysm in a mammal with certain rho kinase inhibitors.
    Type: Application
    Filed: December 10, 2018
    Publication date: October 3, 2019
    Inventors: Kenneth M. ROSEN, Steven Wayne RIESINGER, Lisa MCKERRACHER, Lisa BOND MORITZ
  • Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
    Patent number: 10149856
    Abstract: Provided are methods of treating a cerebral cavernous malformation (CCM) and methods of treating cerebral aneurysm in a mammal with certain rho kinase inhibitors.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: December 11, 2018
    Assignee: BioAxone BioSciences, Inc.
    Inventors: Kenneth M. Rosen, Steven Wayne Riesinger, Lisa McKerracher, Lisa Bond Moritz
  • TREATMENT OF CEREBRAL CAVERNOUS MALFORMATIONS AND CEREBRAL ANEURYSMS WITH RHO KINASE INHIBITORS
    Publication number: 20170246181
    Abstract: Provided are methods of treating a cerebral cavernous malformation (CCM) and methods of treating cerebral aneurysm in a mammal with certain rho kinase inhibitors.
    Type: Application
    Filed: May 9, 2017
    Publication date: August 31, 2017
    Inventors: Kenneth M. Rosen, Steven Wayne Riesinger, Lisa McKerracher, Lisa Bond Mortiz
  • &agr;-hydroxyarylbutanamine inhibitors of aspartyl protease
    Patent number: 6696494
    Abstract: Acylated &agr;-hydroxyarylbutanamines and related sulfonamides, ureas and carbamates that inhibit aspartyl protease are disclosed, as are methods of treating diseases, particularly HIV, using these compounds.
    Type: Grant
    Filed: October 22, 2001
    Date of Patent: February 24, 2004
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Yat Sun Or, Guoqiang Wang, John Rougas, Jude Elizabeth Mathews, Kate Ryan Muldoon, Vincent Alfred Boyd, Jens Werner Eckstein, Steven Wayne Riesinger
  • Nitrogen heterocycle inhibitors of aspartyl protease
    Patent number: 6673821
    Abstract: Nitrogen heterocycles that inhibit aspartyl protease are disclosed, as are methods of treating diseases, particularly HIV, using these compounds.
    Type: Grant
    Filed: October 22, 2001
    Date of Patent: January 6, 2004
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Guoqiang Wang, Yat Sun Or, John Rougas, Steven Wayne Riesinger
  • Alpha-hydroxyarylbutanamine inhibitors of aspartyl protease
    Publication number: 20030207934
    Abstract: Acylated &agr;-hydroxyarylbutanamines and related sulfonamides, ureas and carbamates that inhibit aspartyl protease are disclosed, as are methods of treating diseases, particularly HIV, using these compounds.
    Type: Application
    Filed: October 22, 2001
    Publication date: November 6, 2003
    Inventors: Yat Sun Or, Guoqiang Wang, John Rougas, Jude Elizabeth Mathews, Kate Ryan Muldoon, Vincent Alfred Boyd, Jens Werner Eckstein, Steven Wayne Riesinger
  • Nitrogen heterocycle inhibitors of aspartyl protease
    Publication number: 20030114500
    Abstract: Nitrogen heterocycles that inhibit aspartyl protease are disclosed, as are methods of treating diseases, particularly HIV, using these compounds.
    Type: Application
    Filed: October 22, 2001
    Publication date: June 19, 2003
    Inventors: Guoqiang Wang, Yat Sun Or, John Rougas, Steven Wayne Riesinger